Karen Bergman | VP of IR and Corporate Communications |
Tom Neff | CEO |
Seth Porter | VP of Fibrosis Therapeutics |
Peony Yu | Chief Medical Officer |
Pat Cotroneo | CFO |
Elias Kouchakji | SVP, Clinical Development, Drug Safety and Pharmacovigilance |
Joel Beatty | Citi |
Michael Yee | Jefferies |
Geoffrey Porges | Leerink |
Andy Hsieh | William Blair |
Welcome to the FibroGen Incorporated First Quarter 2018 Financial Results Conference Call. My name is Michelle and I'll be your operator for today's conference. At this time, all participants are in a listen-only mode.
As a reminder, this conference is being recorded.
For opening remarks and introduction, I will now turn the call over to Karen Bergman, Vice President of Investor Relations and Corporate Communications.